SciTransfer
Organization

ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE

Italian eHealth research centre with expertise in digital health interoperability standards and pan-European paediatric clinical trial networks.

Research institutehealthITThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€244K
Unique partners
75
What they do

Their core work

Arsenal.IT is the Veneto region's dedicated research centre for digital health innovation, headquartered in Treviso, Italy. Their work sits at the intersection of eHealth technology, clinical data infrastructure, and regulatory standards — they help healthcare systems speak the same digital language and support the design of clinical research networks. In the EURO-CAS project they contributed to defining EU-wide conformity assessment schemes for eHealth interoperability, and in the c4c network they support pan-European infrastructure for running clinical trials in children and adolescents. They function as a regional bridge between Italian healthcare IT capabilities and broader European clinical research coordination.

Core expertise

What they specialise in

eHealth interoperability and conformity assessmentprimary
1 project

Participated in EURO-CAS (2016-2018), which developed the EU eHealth Interoperability Conformity Assessment Scheme.

Pediatric clinical trial networks and infrastructureprimary
1 project

Active participant in c4c (2018-2025), a large RIA consortium building pan-European clinical trial infrastructure specifically for children, adolescents, and neonates.

Clinical research data management and platformssecondary
1 project

Keywords from c4c include data, platform, and infrastructure, indicating involvement in clinical data systems supporting drug development in paediatric populations.

Medical education and best practice disseminationemerging
1 project

c4c keywords include education, expert advice, and best practice, suggesting Arsenal.IT contributes to training and knowledge-sharing components within clinical networks.

Evolution & trajectory

How they've shifted over time

Early focus
eHealth interoperability standards
Recent focus
Pediatric clinical trial infrastructure

Arsenal.IT entered H2020 through a digital health standards project (EURO-CAS, 2016-2018), focused on technical interoperability and conformity assessment schemes — work that is closer to health IT governance than clinical science. Their second project, c4c (2018-2025), represents a clear shift toward clinical research infrastructure: the keyword set is dominated by clinical trial, drug development, children, neonates, and expert advice, signalling a move into regulated clinical environments rather than IT standards. The trajectory suggests the organisation is growing from eHealth digitisation expert into a clinical research support and coordination role, particularly for vulnerable patient populations.

Arsenal.IT is moving from digital health standardisation into clinical research network support, with a specific emerging niche around paediatric and neonatal medicine — a regulated, underserved area with growing EU policy attention.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European22 countries collaborated

Arsenal.IT has never led an H2020 project — both participations are as consortium partner, suggesting they contribute specialist capacity rather than drive research agendas. Despite only two projects, they have accumulated 75 unique consortium partners across 22 countries, which means they consistently join large, pan-European networks rather than small bilateral collaborations. This makes them an accessible, non-competing partner for consortia that need regional Italian eHealth or clinical research expertise without a heavyweight lead institution dynamic.

Across just two projects, Arsenal.IT has connected with 75 distinct consortium partners in 22 countries — an unusually wide footprint for such a small portfolio, reflecting their participation in large, multi-partner European networks like c4c. No strong geographic concentration is evident beyond their Italian base.

Why partner with them

What sets them apart

Arsenal.IT occupies a rare dual position: a regional Italian research centre with credibility in both eHealth technical standards and paediatric clinical research networks — two domains that rarely overlap. For consortium builders, this makes them useful as a bridge between health IT infrastructure and clinical trial methodology, particularly in projects touching regulatory compliance or digital tools for clinical data in children. Their non-coordinating posture also means they are unlikely to compete for leadership, making them a low-friction partner for consortia that already have a lead institution.

Notable projects

Highlights from their portfolio

  • c4c
    The largest project by far (EUR 212,500, running to 2025), c4c is a flagship EU network for paediatric clinical trials covering children, adolescents, and neonates — a high-impact, policy-relevant area with direct pharmaceutical and regulatory implications.
  • EURO-CAS
    Arsenal.IT's first H2020 project established their credentials in eHealth interoperability governance at EU level, a foundational capability that distinguishes them from purely clinical research organisations.
Cross-sector capabilities
Digital infrastructure and data platform design (applicable to any sector using large-scale data collection)Regulatory and standards compliance frameworks (transferable to medical devices, digital services)Training and education network coordination (relevant to any consortium with capacity-building components)
Analysis note: Profile is based on only two projects, and the first (EURO-CAS) has no keyword metadata, making early-period characterisation reliant solely on the project title and description. The c4c project runs until 2025, so full outputs and impact are not yet available. The large partner and country counts (75 partners, 22 countries) likely reflect the size of the c4c consortium rather than Arsenal.IT's own network-building activity. Treat all expertise claims as indicative rather than confirmed until more project data is available.